Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells

Cho Hwa Liao, Shiow Lin Pan, Jih Hwa Guh, Che Ming Teng

研究成果: 雜誌貢獻文章同行評審

31 引文 斯高帕斯(Scopus)


Genistein, a natural isoflavone phytoestrogen present in soybeans, has been extensively studied as a chemopreventive or therapeutic agent in several types of cancer. The traditional Asian diet is rich in soy products may explain in part why the incidence of breast cancer in Asian women is relatively low. To improve therapeutic benefits, we investigated the combination of genistein with chemotherapeutic agents in phenotypically dissimilar human breast cancer cells, MCF-7 and MDA-MB-231, in which estrogen receptor expression is positive and negative, respectively. In the present study, genistein significantly decreased cell apoptosis induced by tubulin-binding agents, paclitaxel and vincristine. FACScan analysis revealed that genistein also diminished the accumulation of the G2/M phase in the cell cycle caused by tubulin-binding agents. In situ staining of microtubules revealed that genistein could decrease paclitaxel-induced tubulin polymerization. However, in vivo tubulin polymerization assay revealed that simultaneous treatment of genistein did not change the tubulin/microtubule dynamic. Genistein reduced Bcl-2 phosphorylation triggered by paclitaxel and vincristine without changing Bax protein expression. p53 and p21 expression, monitored by Western blotting, was not altered by genistein. However, the expression of cyclin B1 and CDC2 kinase was markedly decreased in combination with genistein. In conclusion, genistein inversely affected tubulin-binding agent-induced apoptosis via down-regulation of cyclin B1/CDC2 kinase expression resulting in reduced Bcl-2 phosphorylation.
頁(從 - 到)2031-2038
期刊Biochemical Pharmacology
出版狀態已發佈 - 6月 1 2004

ASJC Scopus subject areas

  • 藥理


深入研究「Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells」主題。共同形成了獨特的指紋。